Evidence map›Paper›PMID 41097629›Full record

ReviewCancers2025

Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.

Ajla T Wasti, Gianni Bisogno, Raquel Hladun, Anne-Sophie Defachelles, Michela Casanova, Willemijn B Breunis, Susanne A Gatz, Reineke A Schoot, Andrea Ferrari, Meriel Jenney and 10 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ajla T WastiChildren and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton SM2 5PT, UK.ORCID 0000-0002-0376-0094
Gianni BisognoDepartment of Women's and Children's Health, University of Padua, 35122 Padua, Italy.ORCID 0000-0003-4462-5523
Raquel HladunPediatric Oncology and Hematology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Anne-Sophie DefachellesPediatric and Adolescents/Young Adults Oncology Unit, Centre Oscar Lambret, 59020 Lille, France.ORCID 0000-0002-4277-9871
Michela CasanovaPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.ORCID 0000-0003-0368-7883
Willemijn B BreunisDepartment of Oncology and Children's Research Center, University Children's Hospital of Zürich, 8032 Zürich, Switzerland.
Susanne A GatzDepartment of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.
Reineke A SchootPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Andrea FerrariPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.ORCID 0000-0002-4724-0517
Meriel JenneyDepartment of Paediatric Oncology, Children's Hospital for Wales, Heath Park, Cardiff CF14 4XW, UK.
Rita AlaggioPathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, 00165 Rome, Italy.
Raquel Davila FajardoPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-4729-825X
Sheila Terwisscha van ScheltingaPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Janet ShipleyDivision of Cancer Biology, The Institute of Cancer Research, Sutton SM2 5NG, UK.
Michael Torsten MeisterPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Rick R van RijnDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-8876-6515
John AndersonDevelopmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.ORCID 0000-0001-7509-3203
Monika Sparber-SauerKlinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), 70174 Stuttgart, Germany.ORCID 0000-0001-9551-2399
Julia C ChisholmChildren and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton SM2 5PT, UK.ORCID 0000-0003-3479-7997
Johannes H M MerksPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0001-7659-1028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young people. Despite the advances in multimodality treatment over recent decades through successive prospective clinical trials, improved rates of survival for patients are mainly limited to those with localised RMS without adverse biologic features. Current clinicopathologic prognostic factors include

Indexed as

adolescentchemotherapychildmetastaticnovel approachesradiotherapyrelapserhabdomyosarcomasurgeryyoung adult

Identifiers

PMID41097629
PMCPMC12524314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.